Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smartphone-Based ELISA Developed for Blood Antigens

By LabMedica International staff writers
Posted on 14 Aug 2017
A novel high speed, lab-on-a-chip ELISA test for antigens in blood samples depends on a unique nonstick polymer coating that eliminates the need for multiple incubation and washing steps.

Investigators at Duke University (Durham, NC, USA) used an ink-jet printer to spray an array of antibodies onto glass slides treated with a unique nonstick polymer brush coating. More...
The coating functioned like Teflon to prevent non-target proteins from attaching to the surface of the slide and causing high levels of background "noise".

The investigators "D4 assay" utilized a matched pair of antibodies to detect and capture a target protein in a blood sample. The fixed array on the slide comprised immobilized capture antibodies and soluble detection antibodies, which were labeled with a fluorescent marker to allow quantitation of the antigen (if present). Placing a drop of blood on the slide caused the detection antibodies to dissolve, separate from the array, and bind to target proteins in the sample. The fluorescing antibody-antigen pairs then attached to the capture antibodies on the slide. A buffer solution was used to remove any proteins not bound to the slide's nonstick polymer brush coating. Assay results were read with a smartphone based detector system.

As a proof-of-concept for the accuracy of the assay, the investigators measured the levels of leptin in patients' serum with the D4 assay and compared them to those obtained with a clinical ELISA platform. This study found that the results from the D4 assay were on par with those from the ELISA test.

"The real significance of the assay is the polymer brush coating," said senior author Dr. Ashutosh Chilkoti, professor of biomedical engineering at Duke University. "The polymer brush allowed us to store all of the tools we need on the chip while maintaining a simple design."

The D4 system was discussed in detail in the August 7, 2017, online edition of the Proceedings of the [U.S.] National Academy of Sciences.

Related Links:
Duke University


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.